Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Astrana HealthASTH +3.74%87 Free Cash Flow per Share is $1.92 as of Jun. 2026. GuruFocus rates ASTH with a GF Score™ of 87/100 and a GF Value™ of $66.24 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 466 Healthcare Providers & Services companies, Astrana Health ranks better than 54.72% on this metric.
Astrana Health's Free Cash Flow per Share for the
three
months ended in Jun. 2026 was $0.58.
Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 was $1.92.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Astrana Health was -22.20% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 17.70% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the FCF Growth Rate using Free Cash Flow per Share data.
The historical rank and industry rank for Astrana Health's Free Cash Flow per Share or its related term are showing as below:
ASTH'
s 3-Year FCF Growth Rate Range Over the Past 10 Years
Min: -63.5 Med: 7.3 Max: 55.2
Current: 17.7
During the past 13 years, Astrana Health's highest 3-Year average Free Cash Flow per Share Growth Rate was 55.20% per year. The lowest was -63.50% per year. And the median was 7.30% per year.
ASTH's 3-Year FCF Growth Rate is ranked better than 54.72% of 466
companies
in the Healthcare Providers & Services industry
Industry Median: 11.75
vs ASTH: 17.70
Astrana Health (NAS:ASTH) Free Cash Flow per Share Explanation
Free Cash Flow is very close to Warren Buffett's definition of Owner's Earnings, except that in Warren Buffett's Owner's Earnings, the spending for Property, Plant, and Equipment is only for maintenance (replacement), while in the Free Cash Flow calculation, the cost of new Property, Plant, and Equipment due to business expansion is also deducted. There, Free Cash Flow is more conservative than Owner's Earnings.
In Don Yacktman's calculation of forward rate of return, he uses Free Cash Flow for the calculation. Yacktman explained the forward rate of return concept in detail in his interview with GuruFocus. Yacktman defines forward rate of return as the normalized free cash flow yield plus real growth plus inflation.
This is what Yacktman said in his March 2012 interview - when the S&P 500 was at 1400:
If the business is stable, this calculation is fairly straightforward. For instance, on the S&P 500 we would normalize earnings. We would then calculate what percentage of those earnings are not reinvested in the underlying businesses and are therefore free. Historically, for the S&P 500, this has been just under 50% of earnings. Currently, we expect the S&P to earn about 70 on a normalized basis, a number which is far below reported earnings due to our adjusting for record high profit margins. $70 X ½ / 1400 gives you a normalized free cash flow yield of approximately 2.5%.
The historical real growth rate of the S&P 500 (companies) is about 1.5%. Assuming an inflation rate of 2.5%, the forward rate of return on an investment in the S&P 500 is about 6.5% today (2.5% free cash flow yield plus 1.5% real growth plus 2.5% inflation).
For the growth part of the Forward Rate of Return calculation, GuruFocus uses the 5-year average growth rate of EBITDA per share as the growth rate, and the growth rate is always capped at 20%. For the Free Cash Flow we use per share data averaged over five years. The reason we use five years is because research shows that five years is the length of the typical business cycle.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Free Cash Flow within a report period can be affected by management's decisions of capital spending. Therefore, it is important to look at long term when it comes to Free Cash Flow.
Astrana Health Free Cash Flow per Share Related Terms
Astrana Health Free Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Astrana Health's Free Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASTH vs SNDA, SGRY, ADUS: Free Cash Flow per Share Comparison
For the Medical Care Facilities subindustry, Astrana Health's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astrana Health Price-to-Free-Cash-Flow vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Astrana Health's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Astrana Health's Price-to-Free-Cash-Flow falls into.
Astrana Health Free Cash Flow per Share Calculation
Free Cashflow per Share is the amount of Free Cashflow per outstanding share of the company's stock.
Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company.
Note: GuruFocus does not calculate Free Cash Flow Per Share when Capital Expenditure is 0.
Astrana Health's Free Cash Flow Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Free Cash Flow per Share of $1.92 mean?
Astrana Health (ASTH) has a Free Cash Flow per Share of $1.92 as of Jun. 2026. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Astrana Health and its competitors. According to the industry distribution chart, Astrana Health ranks #211 out of 466 companies in the Healthcare Providers & Services industry, placing it in the top 45.3%.
Is Astrana Health's Free Cash Flow per Share too high?
Astrana Health's current Free Cash Flow per Share is $1.92. The Healthcare Providers & Services industry median Free Cash Flow per Share is 11.75. Astrana Health's value of $1.92 is 83.7% below this industry median. Based on the distribution chart, Astrana Health ranks #211 out of 466 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Astrana Health has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astrana Health's Free Cash Flow per Share compare to SNDA and SGRY?
According to the Healthcare Providers & Services industry distribution chart, Astrana Health ranks #211 out of 466 companies for Free Cash Flow per Share. This puts Astrana Health in the upper half of its industry. The industry median Free Cash Flow per Share is 11.75. Astrana Health's value of $1.92 is 83.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Free Cash Flow per Share for a Healthcare Providers & Services company?
The median Free Cash Flow per Share among Healthcare Providers & Services companies is 11.75, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Free Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Free Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Astrana Health's current Free Cash Flow per Share of $1.92 is 83.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Free Cash Flow per Share mean?
A high Free Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Free cash flow per share represents the pre-share value of cash following operating and capital expenditures. View historical data on Astrana Health and its competitors. For the Healthcare Providers & Services industry, the median Free Cash Flow per Share is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astrana Health's current Free Cash Flow per Share is $1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astrana Health stock overvalued right now?
Based on GuruFocus' analysis, Astrana Health (ASTH) is currently considered Significantly Undervalued. The stock's GF Value™ is $66.24, compared to a current price of $34.81 — trading 47.5% below its estimated fair value. The current Free Cash Flow per Share is $1.92 and 83.7% below the Healthcare Providers & Services industry median of 11.75. Astrana Health's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Free Cash Flow per Share calculated?
Free Cash Flow per Share is calculated from a company's financial statements. For Astrana Health (ASTH), the current Free Cash Flow per Share is $1.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astrana Health (ASTH) Overvalued in 2026?
Based on GuruFocus' analysis, Astrana Health stock appears to be undervalued.
The current stock price of $34.81 is trading 47.5% below its estimated GF Value™ of $66.24.
GuruFocus considers Astrana Health to be Significantly Undervalued.
Key valuation signals for ASTH:
Free Cash Flow per Share: $1.92
GF Value™: $66.24 vs. price of $34.81 (47.5% below fair value)
Industry Position: 83.7% below the Healthcare Providers & Services median (#211 of 466)
No single metric tells the full story. See the ASTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astrana Health Inc. is a healthcare company that operates physician-centric, value-based care networks in the United States. It manages care for patients, particularly seniors and those with chronic conditions, through a model that emphasizes population health management and coordinated, outcomes-based medical care. The company operates through three reportable segments: Care Partners, which manages risk-based contracts and independent physician associations; Care Delivery, which provides direct patient care through clinics and medical groups; and Care Enablement, which offers management services, technology, and administrative support to providers. Astrana generates revenue primarily from capitated and risk-sharing arrangements with health plans, including Medicare Advantage, Medicaid, and commercial payers, as well as fee-for-service billing. Its operations are concentrated in California and other U.S. markets, where it partners with health plans, hospitals, and physician groups to deliver integrated care.
87GF Score
Get the complete analysis for ASTH
Free Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASTH has been successfully added to your 
